NVAX Competitors & Alternatives
Compare Novavax Inc with similar stocks in the same industry
Biotechnology
NVAX
Main Stock$10.60
Tradestie Score
33
Market Cap
$1.54B
Revenue Growth
-0.8%
Analyst Upside
+32.1%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CELC
Celcuity Inc. Common Stock
|
$75.13
|
$1.92B | - | 43 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$27.99
|
$1.90B | 9.2 | 41 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$30.99
|
$1.84B | - | 47 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$30.54
|
$1.81B | - | 74 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$13.91
|
$1.78B | - | 34 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$15.82
|
$1.78B | - | 50 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$188.05
|
$1.77B | - | 48 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$18.99
|
$1.74B | - | 57 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$32.18
|
$1.68B | - | 59 | Compare |
|
MNKD
Mannkind Corporation
|
$3.95
|
$1.65B | - | 36 | Compare |
More NVAX Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2836)
231 stocks in this industry